Whether the inflammatory reaction, which is reflected by increased CRP serum levels, can be treated with anti-inflammatory drugs in order to improve prognosis—as investigated in other solid tumors, such as colorectal cancer—is unclear to date [25]. Here, CRP is linked to colorectal cancer.